Federal Register
Notices
> Manufacturers 2008 >
Noramco Inc.,
FR Doc E8-6385[Federal Register: March 28, 2008 (Volume 73, Number 61)]
[Notices] [Page 16712] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr28mr08-112]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated December 17, 2007, and published in the Federal Register on
December 27, 2007, (72 FR 73360), Noramco, Inc., Division of Ortho, McNeil,
Inc., 500 Swedes Landing Road, Wilmington, Delaware 19801, made application by
renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the basic classes of controlled substances listed in schedules I
and II:
Drug
|
Schedule
|
Codeine-N-oxide (9053)
|
I
|
Morphine-N-oxide (9307)
|
I
|
Dihydromorphine (9145)
|
I
|
Codeine (9050)
|
II
|
Dihydrocodeine (9120)
|
II
|
Oxycodone (9143)
|
II
|
Hydromorphone (9150)
|
II
|
Hydrocodone (9193)
|
II
|
Morphine (9300)
|
II
|
Thebaine (9333)
|
II
|
Opium extracts (9610)
|
II
|
Opium fluid extract (9620)
|
II
|
Opium tincture (9630)
|
II
|
Opium, powdered (9639)
|
II
|
Opium, granulated (9640)
|
II
|
Oxymorphone (9652)
|
II
|
Alfentanil (9737)
|
II
|
Sufentanil (9740)
|
II
|
Carfentanil (9743)
|
II
|
Fentanyl (9801)
|
II
|
The company plans to bulk manufacture the above listed controlled substances
for sale and distribution to manufacturers for product development and
formulation.
Noramco has withdrawn their request for Opium, raw (9600) and Poppy Straw
(9650).
No comments or objections have been received. DEA has considered the factors
in 21 U.S.C. 823(a) and determined that the registration of Noramco, Inc. to
manufacture the listed basic classes of controlled substances is consistent with
the public interest at this time. DEA has investigated Noramco, Inc. to ensure
that the company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's physical
security systems, verification of the company's compliance with State and local
laws, and a review of the company's background and history. Therefore, pursuant
to 21 U.S.C. 823,
and in accordance with 21
CFR 1301.33, the above named company is granted registration as a bulk
manufacturer of the basic classes of controlled substances listed.
Dated: March 19, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E8-6385 Filed 3-27-08; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|